Approval · Notice of Compliance 31579 · 2023
CEFA-DRI: Notice of Compliance 31579
Issued September 8, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31579
- Date
- September 8, 2023
- Company
- Boehringer Ingelheim Animal Health Canada Inc.Burlington, Ontario, Canada
- Product type
- Veterinary
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the specification for the drug product tests and replacement of the primary container closure system.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CEFA-DRI | 02173255 | Marketed |
Medicinal ingredients
- CEPHAPIRIN BENZATHINE 300 MG per 10ML